| abstract |
The present invention provides compounds of formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or Il (I), pharmaceutically acceptable salts, prodrugs, biologically active metabolites thereof as described herein. , Stereoisomers and isomers, wherein variables are as defined herein. Compounds of the invention are useful for treating immunological and oncological conditions. |